Retail & Wholesale » Retail | China NT Pharma Group Co. Ltd.

China NT Pharma Group Co. Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
951
1,088
1,046
420
697
677
Cost of Goods Sold (COGS) incl. D&A
598
604
491
124
139
177
Gross Income
354
485
554
297
558
500
SG&A Expense
578
391
424
224
290
615
EBIT
225
94
131
-
269
116
Unusual Expense
-
515
2
-
10
453
Non Operating Income/Expense
-
17
1
32
32
2
Interest Expense
95
99
34
34
50
96
Pretax Income
824
22
134
42
261
666
Income Tax
26
19
16
13
18
47
Equity in Affiliates
-
-
10
-
-
-
Consolidated Net Income
850
3
108
29
243
713
Net Income
850
3
108
29
247
706
Net Income After Extraordinaries
850
3
108
77
303
277
Net Income Available to Common
850
3
108
136
190
1,134
EPS (Basic)
0.79
0.00
0.08
0.09
0.12
0.72
Basic Shares Outstanding
1,082
1,082
1,417
1,548
1,542
1,566
EPS (Diluted)
0.79
0.00
0.08
0.09
0.11
0.72
Diluted Shares Outstanding
1,082
1,082
1,428
1,557
1,712
1,566
EBITDA
190
122
150
96
305
75
Non-Operating Interest Income
-
28
27
7
3
2
Minority Interest Expense
-
-
-
-
4
7

About China NT Pharma Group Co.

View Profile
Address
Unit 1505, 15th Floor
Hong Kong
Hong Kong
Employees -
Website http://www.ntpharma.com
Updated 07/08/2019
China NT Pharma Group Co., Ltd. is a pharmaceutical company, which engages in the provision of distribution, promotion, manufacturing as well as research and development of pharmaceuticals and vaccines. It operates through the following segments: Proprietary Products Production and Sales, and Miacalcic. The Proprietary Products Production and Sales segment engages in the production and sales of the company branded products and generic drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.